Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,480 | 446 | 51.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,000 | 3 | 36.4% |
| Honoraria | $2,000 | 1 | 12.1% |
| Education | $7.29 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $8,000 | 4 | $0 (2022) |
| AbbVie Inc. | $1,672 | 67 | $0 (2023) |
| Amgen Inc. | $1,150 | 62 | $0 (2023) |
| UCB, Inc. | $766.34 | 29 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $694.00 | 35 | $0 (2023) |
| Horizon Therapeutics plc | $616.87 | 38 | $0 (2023) |
| Janssen Biotech, Inc. | $564.07 | 60 | $0 (2023) |
| GlaxoSmithKline, LLC. | $532.69 | 24 | $0 (2023) |
| PFIZER INC. | $530.60 | 31 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $407.27 | 19 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $2,419 | 100 | AbbVie Inc. ($452.53) |
| 2022 | $8,383 | 131 | Hikma Pharmaceuticals USA ($6,000) |
| 2021 | $4,375 | 157 | Hikma Pharmaceuticals USA ($2,000) |
| 2020 | $877.76 | 55 | E.R. Squibb & Sons, L.L.C. ($211.02) |
| 2019 | $432.31 | 8 | AbbVie, Inc. ($249.81) |
All Payment Transactions
451 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: IMMUNOLOGY | ||||||
| 09/13/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $33.95 | General |
| Category: Dermatology | ||||||
| 08/30/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: IMMUNOLOGY | ||||||
| 08/21/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: IMMUNOLOGY | ||||||
| 08/16/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $33.95 | General |
| Category: Dermatology | ||||||
| 07/31/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $11.07 | General |
| Category: Bone Health | ||||||
| 07/27/2023 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Immunology | ||||||
| 07/26/2023 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 07/25/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | CYLTEZO (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: CNS | ||||||
| 07/24/2023 | Octapharma USA, Inc. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Biological) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: IMMUNOLOGY | ||||||
| 07/20/2023 | PFIZER INC. | XELJANZ (Drug), COMIRNATY | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 07/20/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: IMMUNOLOGY | ||||||
| 07/19/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: Immunology | ||||||
| 07/19/2023 | Organon LLC | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 07/13/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $33.95 | General |
| Category: Dermatology | ||||||
| 07/12/2023 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Inflammation | ||||||
| 07/11/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $32.67 | General |
| Category: Immunology | ||||||
| 07/10/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: IMMUNOLOGY | ||||||
| 07/07/2023 | AbbVie Inc. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: IMMUNOLOGY | ||||||
| 07/05/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: KRYSTEXXA | ||||||
| 06/30/2023 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Immunology | ||||||
| 06/28/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.00 | General |
| 06/27/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: IMMUNOLOGY | ||||||
| 06/22/2023 | Amgen Inc. | Enbrel (Biological), TAVNEOS | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: Inflammation | ||||||
| 06/21/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $29.21 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 386 | 12,684 | $277,712 | $110,536 |
| 2022 | 20 | 757 | 40,727 | $779,683 | $372,103 |
| 2021 | 19 | 732 | 29,212 | $565,377 | $329,282 |
| 2020 | 21 | 771 | 5,264 | $332,453 | $183,809 |
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 34 | 2,160 | $97,200 | $38,712 | 39.8% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 12 | 10,000 | $102,500 | $37,011 | 36.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 157 | 276 | $51,907 | $24,184 | 46.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 90 | 116 | $15,426 | $6,400 | 41.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $4,924 | $1,969 | 40.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 20 | 24 | $3,508 | $1,370 | 39.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 42 | 71 | $1,772 | $771.32 | 43.5% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 13 | 19 | $475.00 | $119.85 | 25.2% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 21 | 33,600 | $344,400 | $148,869 | 43.2% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 15 | 2,825 | $173,750 | $97,771 | 56.3% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 29 | 2,940 | $89,100 | $50,125 | 56.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 210 | 480 | $86,134 | $41,696 | 48.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 98 | 136 | $17,021 | $8,575 | 50.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 64 | 64 | $17,464 | $7,987 | 45.7% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 13 | 72 | $6,840 | $3,983 | 58.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 28 | 53 | $9,240 | $3,242 | 35.1% |
| 86235 | Measurement of antibody for assessment of autoimmune disorder, any method | Office | 2022 | 20 | 140 | $7,000 | $2,473 | 35.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 55 | 62 | $7,453 | $2,236 | 30.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 22 | 42 | $12,600 | $2,130 | 16.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 43 | 133 | $3,325 | $1,427 | 42.9% |
| 83516 | Analysis of substance using immunoassay technique, multiple step method | Office | 2022 | 18 | 36 | $1,152 | $388.80 | 33.8% |
| 86225 | Measurement of dna antibody, native or double stranded | Office | 2022 | 19 | 19 | $760.00 | $257.27 | 33.9% |
| 86226 | Measurement of dna antibody, single stranded | Office | 2022 | 19 | 19 | $665.00 | $226.73 | 34.1% |
| 86200 | Measurement of antibody for rheumatoid arthritis assessment | Office | 2022 | 17 | 17 | $629.00 | $205.50 | 32.7% |
| 86038 | Screening test for autoimmune disorder | Office | 2022 | 18 | 18 | $630.00 | $203.61 | 32.3% |
About Dr. William White, MD
Dr. William White, MD is a Rheumatology healthcare provider based in San Antonio, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467425686.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William White, MD has received a total of $16,487 in payments from pharmaceutical and medical device companies, with $2,419 received in 2023. These payments were reported across 451 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($8,480).
As a Medicare-enrolled provider, White has provided services to 2,646 Medicare beneficiaries, totaling 87,887 services with total Medicare billing of $995,730. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Practice Information
- Specialty Rheumatology
- Location San Antonio, TX
- Active Since 02/08/2006
- Last Updated 04/11/2011
- Taxonomy Code 207RR0500X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1467425686
Products in Payments
- Edarbi (Drug) $2,000
- RINVOQ (Biological) $1,078
- Cimzia (Drug) $766.34
- Enbrel (Biological) $692.19
- BENLYSTA (Biological) $532.69
- KRYSTEXXA (Biological) $518.54
- XELJANZ (Drug) $477.66
- COSENTYX (Biological) $469.94
- REMICADE (Biological) $415.55
- ORENCIA (Biological) $407.27
- TALTZ (Drug) $325.70
- EVENITY (Biological) $320.57
- Humira (Biological) $230.61
- Rituxan (Biological) $225.50
- COSENTYX (Drug) $224.06
- SAPHNELO (Biological) $153.60
- HUMIRA (Biological) $114.16
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Biological) $104.44
- Zilretta (Drug) $90.88
- TREMFYA (Drug) $88.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in San Antonio
Dr. Pendleton Wickersham, M.d, M.D
Rheumatology — Payments: $1.1M
Dr. Alex De Jesus, Md, MD
Rheumatology — Payments: $273,995
Kevin Kempf, Md, MD
Rheumatology — Payments: $154,966
Dr. Thomas Rennie, M.d, M.D
Rheumatology — Payments: $135,935
Dr. Fernando Silva, M.d, M.D
Rheumatology — Payments: $53,617
Everett Allen, Md, MD
Rheumatology — Payments: $28,103